Senior Scientist, Clinical Pharmacology
Abata TherapeuticsFull Time
Senior (5 to 8 years)
Millbrae, California, United States
Key technologies and capabilities for this role
Common questions about this position
The role requires a minimum of 3 days a week of onsite presence (or more as business needs require) in either Jersey City (NJ) or Millbrae (CA) offices.
Responsibilities include leading aspects of clinical/scientific execution of protocols, serving as lead clinical scientist on trial teams, leading medical monitoring, collaborating on protocol development and study materials, ensuring CRF design aligns with protocols, monitoring clinical data quality, and providing mentorship to other scientists.
They seek a data-driven and collaborative integrator passionate about therapeutic strategy, with exemplary communication and presentation skills, and the ability to lead study development using current electronic document conventions to ensure scientific and data integrity.
This information is not specified in the job description.
The role involves working as part of a cross-functional clinical development team with collaboration across Clinical Research, Pharmacovigilance, Clinical Operations, and others, supporting significant team growth in an environment focused on high-performance delivery of clinical studies.
Biotech startup developing innovative medicines
Eikon Therapeutics focuses on discovering and developing new medicines in the pharmaceutical industry. The company employs advanced technologies to study biological systems, aiming to identify new drug targets by examining the dynamic aspects of biology rather than just static chemical processes. Their team consists of diverse professionals, including data scientists, chemists, and engineers, which allows them to combine science and engineering to create new therapies that aim to improve and extend life. A key feature of Eikon's approach is their proprietary single-molecule tracking (SMT) platform, which enables rapid visualization of protein movements in living cells. This technology, along with artificial intelligence and automation, allows for precise inventorying of molecular interactions. Eikon Therapeutics targets patients with serious diseases who need effective treatments, generating revenue through the development and commercialization of their therapies.